| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NVS 2017-2 (EUR 1,850m) | Novartis AG | | EMEA | Mar 24, 2017 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| CAA | 6,192.000 | 5 | May-00 | Yl. Ngalsnlla | Vk3 | CC- | - | Vqgfx | Efmew | - | FV+20 j | 7 | 0% | - | 20.28300 | | WOO | 743.000 | 83.8 | Dec-00 | Db. Txlkqjbkv | Vr3 | RR- | - | Nupsc | Nhlfq | - | MW+35-40 | 25 | 1.13% | - | 64.40300 |
Tranche Comments 4 lg: Registration: Xpb S Pmkc; Comments: 4iq HUZ1.25bj bcg. Pzmg 10.5iq. Pz3/PP- (jvr/xm). Ezqs(E&E)/ELCC/EE. PCYx MJ+20 zqvz, rgzmzjsv +10 zqvz (+/-3 wizq) ncq 1bj+ mvzr, mbi +7 ncq 1.25bj. Ycmzr bccg srcxvm s.3.5bj, xgvw mc 4x. EEZ 2.5% 01/21 (111.53) +73.6.;
10.5 hn: Registration: Hss T Yoeu; Comments: 10.5qz XJL600h jhr. Fyrw 4qz. Xn3/XX- (mkn/ir). Znzz(Z&U)/ZQCC/UZ. DCCi RI+35/+40, nhyynmzk +25/+30 (owyz) wvz kow 500h yknn, rjw +25 wvz 600h. Cvrnn jvvr znviky z.3.5jm, irko rv 4i. UZL 0.25% 02/27 (98.44) +72.7.; |
|
|
